Circulation: Genomic and Precision Medicine

NOVEMBER 28, 2023

Background:Proteomic profiling could potentially disclose new pathophysiological pathways for cardiovascular diseases (CVD) and improve prediction at the individual level. In separate meta-analyses for each of the 3 CVD outcomes, 49 proteins were related to myocardial infarction, 34 to ischemic stroke, and 109 to heart failure.

Cardiovascular Disease 40

Cardiovascular Disease Myocardial Infarction Obesity Heart Failure 40

Dr. Paddy Barrett

APRIL 5, 2024

Reducing weight back to normal ranges is a useful strategy for reducing future cardiovascular risk. New obesity medications such as GLP-1 agonists have shown significant reductions in weight in those with a prior heart attack. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. J Am Heart Assoc.

Heart Disease 117

Heart Disease Coronary Artery Disease Heart Attack Heart attacks 117

Journal of the American Heart Association

FEBRUARY 8, 2025

BackgroundObesity and hypercholesterolemia independently increase cardiovascular disease risk. ResultsIn people with obesity, bempedoic acid resulted in placebocorrected reductions in lowdensity lipoprotein cholesterol of 22.5% Journal of the American Heart Association, Ahead of Print. and hsCRP of 23.2% at 6 months.

Obesity 40

Obesity Outcomes Cholesterol Myocardial Infarction 40

DAIC

FEBRUARY 29, 2024

Clinical and Investigative Horizons (Session 410) Sunday, April 7 4:30 – 5:45 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Cardiometabolic Health Congress

JUNE 20, 2024

Dr. Pradeep Natarajan (United States of America) suggested that polygenic risk scores could play a larger role in identifying individuals at risk for cardiovascular disease (CVD). Ultimately, there is an overlap between high-risk primary prevention for cardiovascular disease (CVD) and secondary prevention.

Atherosclerosis 59

Atherosclerosis Cardiovascular Disease Coronary Artery Disease Myocardial Infarction 59

Dr. Paddy Barrett

AUGUST 30, 2024

Obesity is one of the biggest global health concerns we face today. Obesity is also a key driver of risk for cardiovascular disease. Although there are many factors linked to obesity, one factor is certain: excess caloric intake leads to an excess in the energy balance. Obesity (Silver Spring).

Heart Disease 111

Heart Disease Dementia Obesity Heart Attack 111

DAIC

APRIL 6, 2024

The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.

Heart Attack 52

Heart Attack Heart attacks Risk Factors Research 52

Cardiometabolic Health Congress

DECEMBER 5, 2024

The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. View the study.

CME 52

CME Obesity Innovation Cardiovascular Disease 52

Circulation

NOVEMBER 11, 2024

Background:GLP-1 receptor agonists (GLP1RA) agonists have been shown to reduce cardiovascular events in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). Circulation, Volume 150, Issue Suppl_1 , Page A4142589-A4142589, November 12, 2024. SD 6.0], HbA1c: 7.1 % [SD 1.8]

Electrocardiogram 40

Electrocardiogram BMI Myocardial Infarction Obesity 40

Dr. Malcolm Kendrick

AUGUST 26, 2022

26th August 2022 And so, after a great deal of faffing about, my article on cardiovascular disease ‘Assessing cardiovascular disease: looking beyond cholesterol’ has been made free to view. Eric Westman is a staunch ally in the crusade to look at different causal models of cardiovascular disease.

Cardiovascular Disease 40

Cardiovascular Disease Cholesterol Article Plaque 40

Cardiology Update

APRIL 9, 2024

EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI). Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). of patients in the PCI group compared to 3.4%

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Open Heart

MARCH 22, 2025

Objective Historical reductions in cardiovascular disease (CVD) due to lifestyle and treatment improvements are now threatened by factors such as increasing obesity and diabetes, but the relative importance of different risk factors varies by CVD condition.

Cardiovascular Disease 52

Cardiovascular Disease Peripheral Arterial Disease Myocardial Infarction Atrial Fibrillation 52

Cardiometabolic Health Congress

DECEMBER 7, 2023

Published on November 30, 2023, in the Journal of the American College of Cardiology, these new guidelines are based on a comprehensive literature review from May 2022 to November 2022, and provide important recommendations to clinicians caring for patients with or at risk of developing cardiovascular disease (CVD). million.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111

Cardiometabolic Health Congress

MAY 10, 2024

The American Heart Association’s scientific statement, “Psychological Health, Well-Being, and the Mind-Heart-Body Connection,” emphasizes the need to evaluate and address psychological health in patients with or at risk for cardiovascular disease (CVD).

Coronary Artery Disease 59

Coronary Artery Disease Obesity Chest Pain Ischemia 59

MIBHS

DECEMBER 13, 2024

Erectile dysfunction (ED) is a common concern among men, especially those dealing with cardiovascular disease. The connection between heart health, vascular risk factors, and sexual function is well-documented, with poor cardiovascular health often leading to or exacerbating erectile issues.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Diet Heart Disease Risk Factors 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Moreover, cardiovascular disease in women continues to be underrepresented and undertreated.

CME 103

CME Obesity Heart Failure Biomarkers 103